|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.5 EUR | -9.13% |
|
-11.48% | -16.79% |
| 26/04 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
| 26/04 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
Redcare Pharmacy NV reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 791.94 million compared to EUR 592 million a year ago. Net loss was EUR 14.78 million compared to EUR 47.76 million a year ago.
Basic loss per share from continuing operations was EUR 0.79 compared to EUR 2.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.79% | 242.17Cr | |
| -30.37% | 1.57TCr | |
| -22.51% | 1.24TCr | |
| -22.88% | 674.05Cr | |
| -6.01% | 629.23Cr | |
| +11.76% | 626.2Cr | |
| +70.00% | 495.18Cr | |
| -1.90% | 469.51Cr | |
| -5.58% | 402.9Cr | |
| -7.87% | 361.75Cr |
REDCARE PHARMACY NV 
